Scope
Reference
C371747
Description
Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.
Contract 2. Helix Biotech Biosimilar mRNA Vaccines
Supplier
Contract value
- £150,000 excluding VAT
- £180,000 including VAT
Above the relevant threshold
Date signed
17 December 2025
Contract dates
- 18 December 2025 to 17 December 2027
- 2 years
Main procurement category
Goods
CPV classifications
- 33651600 - Vaccines
Contract locations
- UK - United Kingdom
Key performance indicators
| Name | Description | Reporting frequency |
|---|---|---|
| Certificate of Analysis | Certificate of Analysis for each product produced |
12 months |
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Single supplier - technical reasons
Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs). Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.
Supplier
Helix Biotech Inc.
- Public Procurement Organisation Number: PCMD-6995-GBGZ
1460 Breda Drive
Knoxville
37918
United States
Email: info@helix-biotech.com
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 2. Helix Biotech Biosimilar mRNA Vaccines
Contracting authority
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Public Procurement Organisation Number: PBMQ-7576-DVGW
10 South Colonnade
London
E14 4PU
United Kingdom
Contact name: Commercial Preparedness and Medical Countermeasures Team
Email: commercial.preparednessandcountermeasures@ukhsa.gov.uk
Website: https://www.gov.uk/government/organisations/uk-health-security-agency
Region: UKI42 - Tower Hamlets
Organisation type: Public authority - central government